uniQure (QURE) has made great progress to advance several of its gene therapy candidates in the recent year. Interim data was released from the phase I/II U.S. study of AMT-130 for the treatment of ...
The last time I wrote an article on uniQure N.V. (QURE), it was in a Seeking Alpha article entitled "uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting." With respect to that article, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback